Thryv Therapeutics
thryvtrx.comLocations
Laval, QC, Canada · Montreal, QC, Canada · Montréal, QC, Canada
industry
Biotechnology
Size
11 - 50 employees
Stage
Other
founded in
2019
Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T wave and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.
Something looks off?Open jobs at Thryv Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.